A Comprehensive Study of the Male Voice Mutation

This research project is a comprehensive study of the male voice mutation. The beginning of the document will provide a brief history of the approach to the male voice mutation dating back to the ancient Greek and Roman times. Information and pedagogical middle school classroom application of the contemporary voice mutation theories by Duncan McKenzie, Irvin Cooper, Frederick Swanson, and John Cooksey will also be discussed. The second section will include an analysis of individual voice testing results from boys in 5th, 6th, 7th, and 8th grade at Miller South School for the Visual and Performing Arts in Akron, Ohio. Age, previous piano and other music experience, range, pitch matching, tonal memory, sense of rhythm, and vocal strength were evaluated and documented on a standard individual vocal assessment form. The test group of the research were the boys from the 7th grade choir. The project culminated in selecting appropriate choral warm-ups and literature to select for the boys in the 7th grade choir

Resolved Images of Large Cavities in Protoplanetary Transition Disks

Circumstellar disks are thought to experience a rapid "transition" phase in their evolution that can have a considerable impact on the formation and early development of planetary systems. We present new and archival high angular resolution (0.3" = 40-75 AU) Submillimeter Array (SMA) observations of the 880 micron dust continuum emission from 12 such transition disks in nearby star-forming regions. In each case, we directly resolve a dust-depleted disk cavity around the central star. Using radiative transfer calculations, we interpret these dust disk structures in a homogeneous, parametric model framework by reproducing their SMA visibilities and SEDs. The cavities in these disks are large (R_cav = 15-73 AU) and substantially depleted of small (~um-sized) dust grains, although their mass contents are still uncertain. The structures of the remnant material at larger radii are comparable to normal disks. We demonstrate that these large cavities are common among the millimeter-bright disk population, comprising at least 20% of the disks in the bright half of the millimeter luminosity (disk mass) distribution. Utilizing these results, we assess some of the physical mechanisms proposed to account for transition disk structures. As has been shown before, photoevaporation models do not produce the large cavity sizes, accretion rates, and disk masses representative of this sample. It would be difficult to achieve a sufficient decrease of the dust optical depths in these cavities by particle growth alone: substantial growth (to meter sizes or beyond) must occur in large (tens of AU) regions of low turbulence without also producing an abundance of small particles. Given those challenges, we suggest instead that the observations are most commensurate with dynamical clearing due to tidal interactions with low-mass companions --young brown dwarfs or giant planets on long-period orbits.Comment: ApJ, in pres

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Yeast dual-affinity biobricks: Progress towards renewable whole-cell biosensors.

Point-of-care (POC) diagnostic biosensors offer a promising solution to improve healthcare, not only in developed parts of the world, but also in resource limited areas that lack adequate medical infrastructure and trained technicians. However, in remote and resource limited settings, cost and storage of traditional POC immunoassays often limit actual deployment. Synthetically engineered biological components ("BioBricks") provide an avenue to reduce costs and simplify assay procedures. In this article, the design and development of an ultra-low cost, whole-cell "renewable" capture reagent for use in POC diagnostic applications is described. Yeast cells were genetically modified to display both single chain variable fragment (scFv) antibodies and gold-binding peptide (GBP) on their surfaces for simple one step enrichment and surface functionalization. Electrochemical impedance spectroscopy (EIS) and fluorescent imaging were used to verify and characterize the binding of cells to gold electrodes. A complete electrochemical detection assay was then performed on screen-printed electrodes fixed with yeast displaying scFv directed to Salmonella outer membrane protein D (OmpD). Electrochemical assays were optimized and cross-validated with established fluorescence techniques. Nanomolar detection limits were observed for both formats

Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury

Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-associated mortality in the US. Previously, we established an immune-mediated TRALI mouse model, wherein mice with cognate antigen were challenged with MHC class I mAb. In this study, when mice housed in a rodent, specific pathogen–free barrier room were challenged with MHC I mAb, there was significant protection from TRALI compared with nonbarrier mice. Priming mice with LPS restored lung injury with mAb challenge. Using TLR4-deficient bone marrow chimeras, the priming phenotype was restricted to animals with WT hematopoietic cells, and depletion of either neutrophils or platelets was protective. Both neutrophils and platelets were sequestered in the lungs of mice with TRALI, and retention of platelets was neutrophil dependent. Interestingly, treatment with aspirin prevented lung injury and mortality, but blocking the P selectin or CD11b/CD18 pathways did not. These data suggest a 2-step mechanism of TRALI: priming of hematopoietic cells, followed by vascular deposition of activated neutrophils and platelets that then mediate the severe lung injury. Furthermore, our data offer an explanation for the increased incidence of TRALI in patients with immune priming conditions, and we suggest what we believe to be a novel therapeutic approach

Concurrent Validity of the Armour39 Heart Rate Monitor Strap

New technology offers potential advantages in physically demanding environments where convenience and comfort are important and accurate and reliable data collection is challenging. Nevertheless, it is important to validate the accuracy and reliability of such biological monitoring systems (BMS) before they are adopted. The purpose of this investigation was to assess the concurrent validity of a new heart rate monitor across a range of exercise intensities and with a large and diverse group of male subjects in a large cohort with diverse physical fitness characteristics. Seventy-five men (age, 23 [+ or -] 4 years; height, 181 [+ or -] 8 cm; body mass, 83 [+ or -] 12 kg; estimated [[??]O.sub.2]peak, 3.16 [+ or -] 0.63 [L x [min.sup.-1]]) volunteered and completed a graded cycle ergometer exercise protocol while heart rate was continuously monitored before, during, and after exercise with the new device (Armour39) and the gold standard (electrocardiogram). The 2-minute stages included sitting, standing, and cycling with 35 W increments until volitional fatigue. The coefficient of determination between mean heart rate values at each stage was [R.sup.2] = 0.99, whereas Pearson correlations (r) at each stage were [greater than or equal to] 0.99. Heart rates during exercise were typically within 1 beat of each other. The Armour39 BMS, therefore, is an acceptable means for the valid and reliable determination of heart rate under various bodily positions and levels of exertion, including maximal exercise intensity